FDA Officially Recommends Removal Of Interchangeability Designation From Biosimilar Labels

Agency Previously Floated The Idea In Draft Guidance In September

 
• By Chloe Kent
  
Pharmacist serving a patient at the counter
Interchangability relates to pharmacy-level substitution, meaning the information may be more suitable in the Purple Book rather than on labeling • Source: Shutterstock

More from Biosimilars

More from Products